细针芯针活检诊断胰腺导管腺癌的组织学特征与取样准确性评估
研究纳入423例临床高度怀疑胰腺腺癌的SharkCore™细针芯针活检标本,来自392例患者(男193例,女199例,平均年龄69岁)。样本中位诊断组织量为30%,常见组织学表现包括单个异型细胞(44%)、促结缔组织增生(36%)、不规则腺体生长模式(68%)等。最终343例确诊腺癌,其中178例仅凭所评估的芯针活检样本确立诊断;68例被判为可疑的病例中78%最终为腺癌。
要点
- 细针芯针活检可提供胰腺腺癌的组织学诊断,中位诊断组织量仅30%。
- 常见组织学特征包括不规则腺体生长、单个异型细胞、促结缔组织增生。
- 判为可疑的芯针活检病例中78%最终确诊为腺癌。
核心结论
- 细针芯针活检可利用已知组织学参数对胰腺腺癌进行组织学诊断。
- 被判为可疑的芯针活检病例常最终代表恶性肿瘤。
研究设计与样本
- 回顾性分析423例临床高度怀疑胰腺腺癌患者的SharkCore™细针芯针活检标本。
- 标本来自392例患者(男193例,女199例;平均年龄69岁),记录诊断组织百分比、肿瘤部位、大小及组织学表现。
- 对143例追加了切片层次。
主要发现
- 样本中位诊断组织量为30%。
- 常见组织学表现:不规则腺体生长模式68%,单个异型细胞44%,核多形性>4:1者39%,上皮条带脱离37%,促结缔组织增生36%,腺腔不完整18%。
- 423例最终临床诊断:腺癌343例,胰腺炎22例,导管内肿瘤或其他良性/低级别病变16例,未知42例(失访)。
- 腺癌病例中,178例仅凭所评估的芯针活检样本确立诊断,30例仅凭细针穿刺活检,89例两者同时,37例后续活检或切除确立。
- 68例芯针活检判为可疑的病例中,78%最终为腺癌。
临床怎么用
- 细针芯针活检可用于胰腺腺癌的组织学诊断,应关注单个异型细胞、促结缔组织增生、不规则腺体生长及核多形性等特征。
- 芯针活检判为可疑的病例应按恶性肿瘤高风险处理,必要时结合细针穿刺或后续活检/切除确认。
局限性
- 42例(失访)最终临床诊断未知,可能影响诊断准确性评估。
- 本研究为单中心回顾性设计,样本中位诊断组织量仅30%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: With the advent of new biopsy devices, fine-needle core biopsy specimens can be obtained from pancreas masses. This study aimed to report the histological spectrum of intrapancreatic adenocarcinoma on fine-needle core biopsy and the accuracy of sampling. METHODS AND RESULTS: We identified 423 SharkCore™ fine-needle core biopsies taken from patients with a high clinical concern for pancreatic adenocarcinoma. For each, we recorded patient age and sex, percentage of diagnostic tissue in each sample and tumour site, size and histological findings. The cases came from 392 patients (193 men, 199 women; mean age 69 years). Median diagnostic tissue amount in the samples was 30%. Common histological findings included desmoplasia (36%), single atypical cells (44%), haphazard glandular growth pattern (68%), nuclear pleomorphism > 4:1 (39%), incomplete gland lumens (18%) and detached atypical epithelial strips (37%). Additional levels were ordered on 143 cases. Final clinical diagnoses associated with the 423 cases were adenocarcinoma (n = 343), pancreatitis (n = 22), intraductal neoplasm or other benign/low-grade process (n = 16) and unknown (n = 42, patients lost to follow-up). Of the adenocarcinoma cases, the diagnosis was established by the evaluated fine-needle core biopsy sample alone in 178, by fine-needle aspiration biopsy alone in 30, by both concurrently in 89 and by subsequent biopsy or resection in 37 cases. Among 68 cases called suspicious on fine-needle core biopsy, 78% ultimately represented adenocarcinoma. CONCLUSIONS: Fine-needle core biopsy allows for histological diagnosis of pancreatic adenocarcinoma, using known histological parameters. Common findings include single atypical cells, desmoplasia, haphazard gland growth and nuclear pleomorphism. Cases interpreted as suspicious often represent malignancy.
引用
- Gonzalez RS, Yin T, Rosenbaum MW, et al. Evaluation of fine-needle core biopsy specimens for pancreatic ductal adenocarcinoma: Diagnostic utility and helpful histological features. Histopathology. 2024. PMID: 38659189. doi:10.1111/his.15199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。